Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease. [electronic resource]
Producer: 20120106Description: 999-1005 p. digitalISSN:- 1522-9645
- Acetates -- administration & dosage
- Aged
- Apolipoproteins B -- metabolism
- C-Reactive Protein -- metabolism
- Cholesterol -- metabolism
- Coronary Disease -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Indoles -- administration & dosage
- Keto Acids
- Male
- Phospholipases A2, Secretory -- antagonists & inhibitors
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.